Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001477449-24-000147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-04 | 2024-05-31 | TDOC | Cave James L. | INTERIM CAO | M - OptEx | — | +2,885 | 12.2K | +31% | — |
| D | 2024-06-04 | 2024-06-03 | TDOC | Cave James L. | INTERIM CAO | S - Sale+OE | $11.16 | -854 | 12.5K | -6% | -$9,531 |
| DM | 2024-06-04 | 2024-05-31 | TDOC | Cave James L. | INTERIM CAO | M - OptEx | $0.00 | -2,885 | 8,139 | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | M | A | 339 | — | 10,787 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 854 | $11.16 | 12,479 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 3 | Common | Common Stock | 2024-05-31 | M | A | 1,162 | — | 13,333 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-05-31 | M | A | 1,001 | — | 11,788 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2024-05-31 | M | A | 383 | — | 12,171 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 6 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 383 | $0.00 | 1,534 | D | — · — to — | 383 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 1,001 | $0.00 | 0 | D | — · — to — | 1,001 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date. |
| 8 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 339 | $0.00 | 1,017 | D | — · — to — | 339 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 9 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 1,162 | $0.00 | 8,139 | D | — · — to — | 1,162 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |